Indeed STAT5A/B locus focal amplification was shown to be sufficient to elicit a growth advantage and disease progression in prostate cancer (Haddad et al, 2013), and similarly here, the STAT3/5 genetic locus was amplified to enhance STAT3/5 expression. The gene discussed is STAT5A; the disease is prostate carcinoma.